Not finding it? Sign in to also search OpenAlex live.
-
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies2022 American Journal of Nephrology article Immunology and Microbiology Complement system in diseases Open access
Carla Nester, Gerald B. Appel, Andrew S. Bomback, Koenraad Peter Bouman, H. Terence Cook, Erica Daina, +14 more
70citations -
Platelets interact with CD169+ macrophages and cDC1 and enhance liposome-induced CD8+ T cell responses2023 Frontiers in Immunology article Immunology and Microbiology Immunotherapy and Immune Responses Open access
Joanna Aleksandra Grabowska, Valentine Léopold, Katarzyna Olesek, Maarten K. Nijen Twilhaar, Alsya J. Affandi, Mieke C. Brouwer, +7 more
10citations -
Activated Microglia-Derived Extracellular Vesicles Elicit a Pro-Inflammatory Astrocytic Response via Cargo-Dependent Mechanisms2026 Biomolecules article Biochemistry, Genetics and Molecular Biology Extracellular vesicles in disease Open access
Miriam Scheld, Nadine Jülich, Katharina Vöhringer, Adib Zendedel, Cordian Beyer, Sebastian Kant, +2 more
9citations -
Replication of 10 novel loci involved in human plasma protein N-glycosylation using MALDI-MS and UHPLC-FD data2026 Glycobiology article Biochemistry, Genetics and Molecular Biology Glycosylation and Glycoproteins Research Open access
Anna N. Timoshchuk, Annemieke Naber, Roderick C. Slieker, Anna G. Soplenkova, Denis E. Maslov, Nadezhda A. Potapova, +8 more
1citations -
Eine chemisch‐proteomische Strategie identifiziert Inhibitoren der Lipoat‐Wiederverwertung in Bakterien und Parasiten2023 Angewandte Chemie article Biochemistry, Genetics and Molecular Biology Biochemical Acid Research Studies Open access
Jan‐Niklas Dienemann, Shuyu Chen, Manuel Hitzenberger, Montana L. Sievert, Stephan M. Hacker, Sean T. Prigge, +3 more
0citations -
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study2024 Annals of the Rheumatic Diseases article Medicine Systemic Lupus Erythematosus Research Open access
Cynthia B. Aranow, Cornelia F Allaart, Zahir Amoura, Ian N Bruce, Patricia C. Cagnoli, Walter Winn Chatham, +15 more
55citations -
Innate immune-gene expression during experimental amyloodiniosis in European seabass (Dicentrarchus labrax)2021 Veterinary Immunology and Immunopathology article Immunology and Microbiology Aquaculture disease management and microbiota Open access
Omkar Vijay Byadgi, Michela Massimo, Ron P. Dirks, Alberto Pallavicini, James E. Bron, J. Ireland, +3 more
16citations -
S182: ORAL IPTACOPAN MONOTHERAPY INCREASES PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELL CLONE SIZE VIA CONTROL OF INTRA- AND EXTRAVASCULAR HEMOLYSIS IN ANTI-C5-TREATED PNH PATIENTS WITH ANEMIA
Antonio Maria Risitano, Alexander Röth, Austin Gladston Kulasekararaj, Phillip Scheinberg, Yutaka Ueda, Eros Di Bona, +28 more
2citations -
Monotherapy Treatment with Zaltenibart (OMS906), an Alternative Pathway Masp-3 Inhibitor, Improved Key Hematologic Parameters in Patients with PNH with a Suboptimal Response to Ravulizumab: Interim Results from a Phase 2 Proof-of-Concept Study
Morag Griffin, Richard J. Kelly, Mathilde Gavillet, Petra Muus, Britta Hoechsmann, W. Jason Cummings, +4 more
4citations -
Plain language summary: treatment of paroxysmal nocturnal hemoglobinuria with pegcetacoplan for 48 weeks (PEGASUS study)2024 Future Rare Diseases article Immunology and Microbiology Complement system in diseases Open access
Régis Peffault de Latour, Jeff Szer, Ilene Ceil Weitz, Alexander Röth, Britta Höchsmann, Jens Panse, +10 more
0citations -
MDS-273 Oral Iptacopan Monotherapy Increases Paroxysmal Nocturnal Hemoglobinuria (PNH) Red Blood Cell Clone Size Via Control of Intra- and Extravascular Hemolysis in Anti-C5-Treated PNH Patients With Anemia2023 Clinical Lymphoma Myeloma & Leukemia conference-abstract Immunology and Microbiology Complement system in diseases Open access
Antonio Maria Risitano, Alexander Röth, Austin Gladston Kulasekararaj, Phillip Scheinberg, Eros Di Bona, Morag Griffin, +27 more
2citations -
Real-world clinical characteristics and treatment outcomes in PNH patients prescribed pegcetacoplan across europe, the United States and Canada2025 Blood conference-abstract Immunology and Microbiology Complement system in diseases Open access
Jens Panse, Koo Wilson, Sam Williamson, Susanna Libby, Peter Hillmen, David Dingli
0citations -
Plain Language Summary of PEGASUS, a Study Comparing Pegcetacoplan with Eculizumab for 16 Weeks in People with Paroxysmal Nocturnal Hemoglobinuria2023 Future Rare Diseases article Immunology and Microbiology Complement system in diseases Open access
Morag Griffin, Jeff Szer, Ilene Ceil Weitz, Alexander Röth, Britta Höchsmann, Jens Panse, +11 more
0citations -
Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria2021 New England Journal of Medicine article Immunology and Microbiology Complement system in diseases Open access cited by 1 patent
Peter Hillmen, Jeff Szer, Ilene Ceil Weitz, Alexander Röth, Britta Höchsmann, Jens Panse, +11 more
407citations